The US FDA has issued a warning against the use of smartwatches or smart ring devices that claim to be able to measure blood glucose levels. The regulator points out that there are no approved ...

CellTrans has claimed the first FDA approval ... type 1 diabetes, i.e. those who are unable to meet their treatment targets because they have repeated episodes of severe low blood glucose ...

“Today’s approval underscores the FDA’s continued ... Type 2 diabetes is a chronic condition that occurs when the body does not use insulin well and cannot keep blood sugar at normal levels.

Today’s approval underscores the FDA’s continued commitment to advancing patient access to safe, effective and high-quality generic drug products.” Liraglutide mimics natural GLP-1 effects, helping to ...

to lower blood sugar in people aged 10 years or older with type 2 diabetes (T2D), as an adjunct to diet and exercise. The move follows the FDA’s approval last month of a generic version of ...